Beijing Tongrentang – Market Snapshot and Strategic Outlook

Trading Performance Beijing Tongrentang (600085.SS) closed unchanged at 0 % during a 24‑hour window ending at 07:23 PM Central Europe on Thursday, 22 October 2026. The share trades at approximately CNY 24.55 on the Shanghai Stock Exchange, with a current float of 1.4 billion shares. The company’s market capitalisation stands at CNY 34.3 billion, while turnover over the last 24 hours totaled roughly CNY 144.2 million. Relative to the month‑end, the stock has risen 5.03 %. Its 200‑day simple moving average is CNY 24.42; the 52‑week high of CNY 35.87 was reached on 14 November 2025, whereas the 52‑week low of CNY 21.87 occurred on 29 June 2026.

Strategic Context The company’s recent IPO activity reflects a broader tightening of capital‑market conditions for medical‑related firms. Following an initial period of robust demand and a wave of applications, many enterprises have either withdrawn their listings or faced extended regulatory scrutiny. Beijing Tongrentang’s decision to pause or revise its public‑offering plans is consonant with a shift in investor expectations: the market now demands tangible commercial performance and solid governance, rather than early‑stage narratives. Consequently, the company’s fundraising prospects remain constrained, and any future market entry will hinge on resolving compliance and financial performance issues. This trend is emblematic of a larger pattern of heightened scrutiny across mainland and Hong Kong markets, prompting a more selective and disciplined approach to new listings in the healthcare sector.

Peer Activity – 24‑Hour Overview

  • Shanghai Zhangjiang High (600895.SS): flat, CNY 26, market cap CNY 41 bn, P/E 44.03.
  • Zheshang Securities (601878.SS): flat, CNY 8.90, market cap CNY 40.5 bn, P/E 13.89. On 22 October 2026, its principal shareholder, Suzhou International Development Group, completed a rapid share‑purchase programme, acquiring 12 million shares in twelve days to reach a 0.25 % stake, with an overall 28.58 % stake when affiliated entities are included. The purchase satisfied the lower threshold of a 1‑to‑2 billion‑yuan plan, and the shareholder indicated intent to continue buying at its own pace. This transaction occurred while the firm was under scrutiny for a pending acquisition of 83.68 % of Donghai Securities, a deal paused for regulatory review due to outdated financial statements. The industry is witnessing a broad acceleration of mergers and acquisitions, supported by policy initiatives from regulators and the China Securities Association that encourage consolidation and strategic integration within the brokerage sector.
  • Qilu Bank (601665.SS): flat, CNY 6.54, market cap CNY 40.7 bn, P/E 7.20.
  • Anhui Gujing Distillery (000596.SZ): flat, CNY 82.40, market cap CNY 40.9 bn, P/E 21.49. On 21 October 2026, Chinese equity markets opened higher across the Shanghai Composite, Shenzhen Component, and ChiNext indices before settling into a broad decline by close. The indices fell by roughly one to one‑and‑a‑half percent, reflecting a general market pullback driven largely by weakness in the battery sector, with notable drops in leading lithium‑ion manufacturers. Other pressured segments included automotive, alcoholic beverages, wind‑turbine equipment, and brokerage stocks. Conversely, the agriculture‑and‑livestock group and certain technology‑focused sub‑sectors such as data‑storage and optical communications posted gains. Trading volume for the two markets fell by about 2‑3 percent compared with the prior day, and a large number of individual stocks recorded losses, underscoring broadly negative sentiment.
  • Sinopharm –H (1099.HK): up 1.95 %, HKD 15.40, market cap HKD 48 bn, P/E 5.89.

Company Overview Beijing Tongrentang Co., Ltd. is a leading healthcare company in China’s pharmaceutical sector, specialising in the development, manufacturing, and marketing of traditional Chinese medicines and medicinal wines. The firm also operates retail pharmaceutical outlets and offers consulting services. More detailed information can be found on the company’s website, www.tongrentang.com . The company was first listed on the Shanghai Stock Exchange on 29 May 1997.